Top search results

At CROI 2024, Dr Aadia Rana from the University of Alabama at Birmingham spoke to aidsmap's Roger Pebody about injectable treatment for people with adherence challenges.

At CROI 2024, Professor Nicholas Paton from the London School of Hygiene and Tropical Medicine spoke to aidsmap's Roger Pebody about injectable HIV treatment in Africa.

At CROI 2024, Dr Amy Colson from the Community Resource Initiative in Boston spoke to aidsmap's Roger Pebody about islatravir and lenacapavir as a once-weekly oral HIV treatment.

With activist Mercy Shibemba; Communications Director at UNAIDS, Ben Phillips; 'London patient' Adam Castillejo; HIV consultant Dr Laura Waters; and writer Gus Cairns. 

 At CROI 2023, Professor Joseph Eron from University of North Carolina spoke to NAM's Roger Pebody about lenacapavir and two broadly neutralising antibodies for treatment.

At HIV Glasgow 2022, Professor Chloe Orkin, from Queen Mary University London, spoke to Roger Pebody about who is at risk of injectable treatment failure.

With Dr Meg Doherty from the World Health Organization; Professor Linda-Gail Bekker from the Desmond Tutu Health Foundation; Dr Laura Waters from the British HIV Association; Florence Anam from the Global Network of People living with HIV; and Winnie Byanyima, Executive Director of UNAIDS.

At IAS 2021, Dr Maggie Czarnogorski of ViiV Healthcare talks about providing injectable HIV treatment.

With Director of Global HIV, Hepatitis and STI Programmes at the World Health Organization, Dr Meg Doherty; Chair of the British HIV Association, Dr Laura Waters; National Co-ordinator of the Kenya Sex Workers Alliance, Phelister Abdalla; and IAS 2021 rapporteur and Chief Medical Information Officer at the University Hospital Rechts der Isar, Germany, Dr Christoph Spinner.

At IAS 2021, Professor Samir Gupta of Indiana University talks about lenacapavir, an experimental capsid inhibitor, for people starting HIV treatment.

Professor Jean-Michel Molina of Hôpital Saint-Louis in Paris talks about injectable lenacapavir, a capsid inhibitor currently under development, for people with multidrug-resistant HIV at IAS 2021.

With Chair of the British HIV Association, Dr Laura Waters; Deputy Director of the Desmond Tutu HIV Centre, Professor Linda-Gail Bekker; AIDS 2020 plenary speaker and Positive Young Women Voices team leader, Lucy Wanjiku Njenga; and NAM aidsmap Editor, Gus Cairns.